Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications characteristics patients prescribed prucalopride versus active comparator england wales
… or surveys , can help you understand: Clinical disease characteristics Disease progression, survival, and treatment … of interest, we select participants based on specific characteristics (e.g., physician specialty, years in … Selected physicians then abstract data from their own patients’ charts based upon patient selection criteria …
… will enable you to demonstrate your products’ value to patients, physicians, caregivers, payers, and policymakers. …
… prevalence and public health impact Event rates Patient characteristics Treatment patterns and drug utilization …
… surveys and observational studies can help you, your patients, regulators, and prescribers understand the … and retention Statistical analysis plans Reports and publications Data Collection and Management Depending upon …
… Page See the research: Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease Layton JB , McGrath … daily incidence of influenza vaccine reactions among patients with end-stage renal disease to inform study design …
Cross-Sectional Survey of Pneumococcal Vaccine Prescribers OPPORTUNITY The CDC’s Advisory Committee on Immunization Practices (ACIP) takes stakeholder acceptability into consideration when establishing recommendations. To anticipate the potential for …
… More than ever, health economic information affects how patients, providers, payers , and regulators make decisions, … Indirect and mixed treatment comparisons and efficacy versus effectiveness analyses Health Technology Assessment …
… pneumococcal disease in Australia, Canada, Israel, England & Wales, and the United States. Perdrizet J, Horn EK, Hayford … pneumococcal disease in Australia, Canada, Israel, England & Wales, and the United States. Perdrizet J, Horn EK, …
… practice Identify clinical and cost effectiveness of comparator treatments Formulate best practices in economic … to understand the efficacy of a treatment of interest versus relevant comparators Potential Deliverables Internal …
… without anticholinergic properties, for at least 4 months versus no treatment on the incidence of dementia: a target … design differed from previous studies in several ways. Active comparator Inverse Probability Weighting Exposure assignment …